ABATEAS (ABATEAS) Fair Value & Analysis
IN · Market cap ₹1.6B
Fair value as of: Jul 5, 2026
From 24 valuation models · updated today
Share price −5.1% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹9.37 – ₹25.87 · fair‑value band ₹5.35 – ₹13.00 · the ₹9.98 price screens below the ₹10.32 fair value. As of Jul 5, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
ABATEAS (ABATEAS) currently trades at ₹9.98, while our model-based Fair Value estimate is ₹10.32 — implying the stock looks roughly 3.4% undervalued today. We read business quality at 44/100 (below-average quality). Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
Over the trailing twelve months, ABATEAS generated revenue of ₹1.6B at a net margin of 7.7%. Revenue grew 140.9% year over year. It earns a return on equity of 6.4%. Net debt stands at ₹60.1M. Fundamentals as of Jul 5, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
ABATEAS reported revenue of ₹1.6B in FY2026 versus ₹0 in FY2022. Reported net income was ₹85.8M in FY2026.
Is ABATEAS fairly valued? → Check now
Explore undervalued stocks
Frequently asked questions
Is ABATEAS (ABATEAS) undervalued?
What is the fair value of ABATEAS?
What is the quality score of ABATEAS?
What is the revenue of ABATEAS (ABATEAS)?
What is the net profit margin of ABATEAS?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.